1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hyaline Membrane Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henderson, WR; Hodson, WA; Jackson, JC; Juul, SE; Murphy, JH; Standaert, TA; Truog, WE | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyaline Membrane Disease
Article | Year |
---|---|
Acute changes in vasoactive lipid mediators in experimental hyaline membrane disease.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Fetal Blood; High-Frequency Ventilation; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Macaca nemestrina; Platelet Activating Factor; Respiration, Artificial; SRS-A; Thromboxane B2; Time Factors | 1992 |